Difference between revisions of "mgh:cyto-2-2"
From MGH Learn Pathology
| Line 1: | Line 1: | ||
__NOCACHE__{{DISPLAYTITLE:2-2 Gyn Cytology}}{{:TOC}} | __NOCACHE__{{DISPLAYTITLE:2-2 Gyn Cytology}}{{:TOC}} | ||
<br> | <br> | ||
| − | + | == HPV Testing Methods; additional tests == | |
* Qiagen Hybrid Capture II : RNA:DNA Hybrid Capture | * Qiagen Hybrid Capture II : RNA:DNA Hybrid Capture | ||
* Cervista: Invader Technology | * Cervista: Invader Technology | ||
| Line 9: | Line 9: | ||
* Biomarkers: -p16INKA4a/CINtec Dual Stain | * Biomarkers: -p16INKA4a/CINtec Dual Stain | ||
| − | + | == Image analysis assisted screening == | |
| − | + | == Guidelines for management of patients with abnormal cervical cytology results == | |
| − | + | == Advanced gyn cytomorphology cases: == | |
* HSIL variants/mimics | * HSIL variants/mimics | ||
* Adenocarcinoma variants/mimics | * Adenocarcinoma variants/mimics | ||
* Radiation change | * Radiation change | ||
{{:mgh:cytology-footer}} | {{:mgh:cytology-footer}} | ||
Latest revision as of 14:29, July 2, 2020
Contents
HPV Testing Methods; additional tests
- Qiagen Hybrid Capture II : RNA:DNA Hybrid Capture
- Cervista: Invader Technology
- Roche Cobas 4800 Real-Time PCR
- Tigris Aptima: mRNA hybrid capture
- In situ Hybridization
- Biomarkers: -p16INKA4a/CINtec Dual Stain
Image analysis assisted screening
Guidelines for management of patients with abnormal cervical cytology results
Advanced gyn cytomorphology cases:
- HSIL variants/mimics
- Adenocarcinoma variants/mimics
- Radiation change
